by Mybiogate | Sep 14, 2020 | Industry Research
Ginger Ding, Chen Lixing Introduction Children ages 0 to 18 account for about 26% of the global population, but the development and market value of pediatric drugs has been seriously underrepresented for a long time. Due to the gradual implementation of the... by Mybiogate | Sep 11, 2020 | Chinese company profile
Jiangsu Hengrui Medicine Co. Ltd 2019 Revenue: US$3.3 Billion Number of Employees: 24,000+ Top 50 Global Pharma Companies: 47 Founded: 1970 Overview Jiangsu Hengrui Pharmaceutical Co., Ltd. is a medical and health enterprise engaged in medical innovation and... by Mybiogate | Sep 11, 2020 | Interview
Author: Xu Ziyi Editor: Ginger Ding In the first half of this year, in addition to new coronavirus-related drugs and vaccines, biotech investors have enthusiastically sought after exosomes. In June 2020, large pharmaceutical companies, such as Takeda... by Mybiogate | Sep 10, 2020 | Interview
Author: Xu Ziyi Editor: Ginger Ding At the beginning of 2019, a story initially reported by Jerusalem Post and picked up by Forbes and other major international news outlets was making the rounds. The headlines read “An Israeli Company Claims That They... by Mybiogate | Sep 10, 2020 | Interview
Author: Xu Ziyi Editor: Ginger Ding For many parents, there is an image of their child in their mind. This child is one who runs carefree, their youth and exuberance frozen in their parents’ memories. For some parents, this sort of happy memory is one that they hold...